Navigation Links
Yale's Scassellati gets Microsoft 'breakthrough research award' for robotics
Date:5/27/2008

Research Award is a tribute to the vision and accomplishments of A. Richard Newton, past professor and dean of the college of engineering at University of California, Berkeley, who died in January of 2007. Further information on the Robots Among Us program and the request for proposals is available at http://www.microsoft.com/presspass/features/2008/may08/05-16HRI.mspx


'/>"/>

Contact: Janet Rettig Emanuel
janet.emanuel@yale.edu
203-432-2157
Yale University
Source:Eurekalert

1

GOOD

Page: 1 2 3

Related medicine news :

1. Microsoft Helps Developers of Clinical User Interfaces Improve Efficiency, Patient Safety With Free Toolkit
2. Moffitt Selects Microsofts Azyxxi to Help Drive Personalized Cancer Treatment
3. SYMX Builds on Top of New Microsoft Technologies to Offer Hospitals Real-Time Business and Patient Safety Solutions Using RFID Data
4. Medifast, Inc. Announces Support for Microsoft HealthVault
5. Allscripts Featured in Microsoft HealthVault Worldwide Launch
6. American Heart Association Announces Debut of Health Management Tool on Microsoft HealthVault
7. Diet.com Enters Strategic Collaboration To Support Microsoft HealthVault
8. LiveHealthier Announces Its Health and Wellness Coaching Solution for Employer Groups is Now Compatible With Microsoft HealthVault
9. Statement Regarding Microsofts Announcement of New Services to Help People Store Their Health Information Online
10. Claricode Announces DoseSpot Built on Microsoft HealthVault
11. Physicians Wellness Network Announces Lab Testing Services for Consumers built on Microsoft HealthVault

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)....,Nov.25 /PRNewswire-FirstCall/-- TheProvidenceS...itsLogistiCaresubsidiary,thenation,slargestcoordin...receivednoticeofawardfromtheStateofFloridaCommissi...idnon-emergencytransportationservicestobothMiami-D...14millioninrevenueovertheinitial18monthterm,issubj...
(Date:11/25/2009)...rovidesFinancialFlexibility,AllowingCompanytoAcces...5/PRNewswire-FirstCall/-LabopharmInc.(TSX:DDS;NASD...uitydistributionagreement(SEDA)withYAGlobalMasterS...etermsoftheagreement,YAhascommittedtoprovideupto$2...rm,sdiscretion,throughthepurchaseofnewlyissuedLabo...
(Date:11/25/2009)...change by reducing carbon dioxide and other greenh...its in addition to reducing the risk of climate ch...g to a series of six papers appearing today (Wed.,... Two University of California, Berkeley, authors o...environmental health, and Michael Jerrett, associa...
(Date:11/25/2009)... Thirty-seven million Americans are afflicte...nvasive technology for treating chronic sinus infl... Jackson, Miss. The Balloon Sinuplasty™ syst...alloon to quickly open and expand blocked sinuses....009 -- A clinically proven, minimally invasive tec...
(Date:11/25/2009)... Beginning Today through Sunday, November 29...memory foam and latex sofa bed mattress + an addit...nd a 100 night money back guarantee. Use the code ...take advantage of this special offer. , ...ns of Americans will travel from Thanksgiving thro...
Breaking Medicine News(10 mins):Health News:Providence Service Corporation's LogistiCare Subsidiary Announces Non-Emergency Medical Transportation Contracts Worth Over $11 Million Annually in Florida 2Health News:Providence Service Corporation's LogistiCare Subsidiary Announces Non-Emergency Medical Transportation Contracts Worth Over $11 Million Annually in Florida 3Health News:Labopharm Enters Into CAD$25 Million Standby Equity Distribution Agreement 2Health News:Labopharm Enters Into CAD$25 Million Standby Equity Distribution Agreement 3Health News:Cutting greenhouse pollutants could directly save millions of lives worldwide 2Health News:Cutting greenhouse pollutants could directly save millions of lives worldwide 3Health News:Novel Technology in Treating Chronic Sinus Infections Available at Baptist 2Health News:Novel Technology in Treating Chronic Sinus Infections Available at Baptist 3Health News:Providing Comfort for Holiday Guests Just Got Easier 2Health News:Providing Comfort for Holiday Guests Just Got Easier 3
...nd Specialty Pharmacy programs expand URAC,s Pharm..., Oct. 28 URAC announced that four,companies have...mail,programs under its Pharmacy Quality Managemen...am of,this scope for the pharmacy benefit manageme...
...esterol-lowering statins is associated with a stat... antigen (PSA) levels, according to a report in th...ational Cancer Institute . , Previous studies exa...ned the association between statins and PSA level....
...., Oct. 28 Dean Barkley,candidate for US Senate f...mprehensive strategy to fight HIV/AIDS in the US a...orm Coleman and other candidates from,Minnesota wi...ed to take a bold stand on this issue.", Barkley ...
...s, Oct. 28 Animal Health,International, Inc. (Nas...,release financial results for its fiscal year 200...y, November 4, 2008. Animal Health,International, ...the conference call by dialing (719) 785-1758.,Par...
...e of the ED drug delayed disease progression, rese...thDay News) -- Cialis (tadalafil), a drug used to ...reating pulmonary hypertension, researchers report... become tired, dizzy and short of breath, because ...
...Oct. 28 WellPoint, Inc. (NYSE:,WLP) announced tod...at the,following conferences:, -- Oppenheimer 19t...,at 2:00 p.m. Eastern Standard Time ("EST"); and, ...invited to listen to webcasts of the,presentations...
Other Medicine News:Health News:Four Companies Are First to Achieve Accreditation Under Two New URAC Pharmacy Quality Management(SM) Programs 2Health News:Statin use associated with reduction in prostate specific antigen levels 2Health News:Senator Dean Barkley Pledges Action on HIV/AIDS Epidemic 2Health News:Cialis May Help Ease Pulmonary Hypertension 2Health News:WellPoint Announces Appearances at Upcoming Conferences 2
(Date:11/25/2009)...ov.25/PRNewswire/--AccordingtoMillenniumResearchGr...etintelligence,thenearly$3billionUSmarketfortrauma...nextfiveyearsdespitetherecenteconomicslowdown.MRG,...hismarketwillremainhighlydynamicoverthenextfiveyea...reviouslyunderservedsegmentsofthetraumafixationmar...
(Date:11/25/2009)...,Nov.25/PRNewswire/--CempraPharmaceuticalsInc.toda...efexecutiveofficer,willpresentatthePiperJaffray21s...,2009,atTheNewYorkPalaceHotelinNewYorkCity.Dr.Fern...antibioticclinicalprogramsforthetreatmentofdrug-re...harmaceuticals ,, Foundedin2006,CempraPharmace...
(Date:11/25/2009)...PRNewswire/--Reportlinker.comannouncesthatanewmark...IntranasalDrugDelivery-USMarketTrends&Analysis...Drug-Delivery---US-Market-Trends--Analysis.html ,...anexpansionoftherapeuticapplicationsfromthedeliver...fsystemictherapeuticdrugs.Thefutureofthetechnology...
Breaking Medicine Technology:US Trauma Fixation Device Market Not Seeing Signs of Slowdown 2US Trauma Fixation Device Market Not Seeing Signs of Slowdown 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5French Physicians to Conduct 2000 Patient Study of CATANIA 28TM 29 Coronary Stent 14671 1French Physicians to Conduct 2000 Patient Study of CATANIA 28TM 29 Coronary Stent 14671 2Shire Reports Tolerability and Clinical Effects Results of Daytrana 28R 29 28methylphenidate transdermal system 29 from Study in Adolescents with ADH 5890 1Shire Reports Tolerability and Clinical Effects Results of Daytrana 28R 29 28methylphenidate transdermal system 29 from Study in Adolescents with ADH 5890 2Shire Reports Tolerability and Clinical Effects Results of Daytrana 28R 29 28methylphenidate transdermal system 29 from Study in Adolescents with ADH 5890 3Shire Reports Tolerability and Clinical Effects Results of Daytrana 28R 29 28methylphenidate transdermal system 29 from Study in Adolescents with ADH 5890 4Shire Reports Tolerability and Clinical Effects Results of Daytrana 28R 29 28methylphenidate transdermal system 29 from Study in Adolescents with ADH 5890 5Shire Reports Tolerability and Clinical Effects Results of Daytrana 28R 29 28methylphenidate transdermal system 29 from Study in Adolescents with ADH 5890 6Shire Reports Tolerability and Clinical Effects Results of Daytrana 28R 29 28methylphenidate transdermal system 29 from Study in Adolescents with ADH 5890 7Antibiotic Resistance Still a Major Public Health Threat 60427 1Antibiotic Resistance Still a Major Public Health Threat 60427 2Antibiotic Resistance Still a Major Public Health Threat 60427 3Antibiotic Resistance Still a Major Public Health Threat 60427 4
...aGen Corporation,(Nasdaq: CRGN ) and TopoTarget A...ay the initiation of patient dosing in a Phase I/I... histone deacetylase (HDAC),inhibitor, in combinat...tment of Acute Myeloid Leukemia (AML). The trial i...n Union. Patients under the age of 60 with relaps...
...ollment follows FDA approval of Zingo in ...CO, Calif., Aug. 28 Anesiva,Inc. (Nasdaq: ANSV )...of the,Phase 3 clinical study of Zingo(TM) (lidoca...injection system to reduce pain associated with,pe..., a fast-acting,topical, needle-free system for lo...
Other Medicine Technology:CuraGen and TopoTarget Initiate Phase I/II Clinical Trial of Belinostat (PXD101) Combination Therapy for Acute Myeloid Leukemia 2CuraGen and TopoTarget Initiate Phase I/II Clinical Trial of Belinostat (PXD101) Combination Therapy for Acute Myeloid Leukemia 3CuraGen and TopoTarget Initiate Phase I/II Clinical Trial of Belinostat (PXD101) Combination Therapy for Acute Myeloid Leukemia 4CuraGen and TopoTarget Initiate Phase I/II Clinical Trial of Belinostat (PXD101) Combination Therapy for Acute Myeloid Leukemia 5CuraGen and TopoTarget Initiate Phase I/II Clinical Trial of Belinostat (PXD101) Combination Therapy for Acute Myeloid Leukemia 6Anesiva Completes Enrollment in Phase 3 Clinical Trial of Zingo(TM) to Treat Pain Associated With Venous Access Procedures in Adults 2Anesiva Completes Enrollment in Phase 3 Clinical Trial of Zingo(TM) to Treat Pain Associated With Venous Access Procedures in Adults 3
Tensiobag
...ilEyes CTR is a device designed for permanent impl...ct removal surgery. It provides secondary capsular...s. The CTR is a uniplanar, 270-degree, semi-circle...ing polymethylmethacrylate (PMMA) with one manipul...
Hannum Ronguer/Grasper
Cobra Retractors
Medicine Products: